The INSIS Metacohort Vaccine Safety Study: A Paradigm for Clinical and Immune AEFI Profiling - Report from WVCDC 2026

Professor Asimenia Angelidou discusses the INSIS Metacohort Vaccine Safety Study, establishing a new paradigm for profiling clinical and immune adverse events following immunization (AEFI) at the World Vaccine Congress Washington 2026.

Video: https://medicaldigest.org/scientific-contents/interview:insis-metacohort-vaccine-safety-study-paradigm-clinical-and-immune-aefi-profiling